Summarizing the MR results presented in the heatmap, we observed that SRA1, SCDF1, SLC25A24, ZSCAN23, and ZSCAN26 were notably associated with glioma risk across at least two cell types, with consistent MR estimates, indicating potential cross‐cell effects of these genes (Figure 2g). This evidence concerns the gene SRA1 and central nervous system cancer.